Loading...
OTCM
KGWMF
Market cap26mUSD
, Last price  
USD
Name

Kingworld Medicines Group Ltd

Chart & Performance

D1W1MN
OTCM:KGWMF chart
P/E
P/S
EPS
0.02
Div Yield, %
Shrs. gr., 5y
-0.94%
Rev. gr., 5y
4.24%
Revenues
917m
-13.55%
556,417,000638,046,000685,562,000705,519,000554,763,000660,323,000713,548,0001,053,527,0001,031,488,0001,078,843,000977,928,000745,383,000847,386,000957,701,0001,078,659,0001,061,082,000917,341,000
Net income
11m
-72.85%
37,244,00042,863,00051,031,00048,535,00047,177,00037,865,00031,205,00046,966,00051,060,00041,005,00043,427,00011,716,00030,319,00022,741,00038,096,00041,557,00011,282,000
CFO
85m
-37.74%
158,647,00013,416,000-53,326,00073,203,000-49,849,000-5,230,000102,790,000-2,207,00072,388,00062,385,000132,711,000123,584,00081,199,000186,548,00042,284,000135,820,00084,559,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kingworld Medicines Group Limited functions as an investment holding company primarily engaged in the distribution of imported, branded pharmaceutical and healthcare items. The company also supplies a range of medical products, health goods, and general food items. Its extensive product catalog caters to various therapeutic areas, such as respiratory relief (for cough and phlegm), gastrointestinal issues, vitamin supplementation, orthopedic support, cardiovascular health, and influenza care. Key brands distributed include Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, the Kawai Product Range, Flying Eagle Wood Lok Medicated Oil, Kyushin Pill, and the Mentholatum Product Range. Furthermore, Kingworld is involved in the production and sale of electrotherapeutic and physiotherapeutic devices, as well as common medical examination equipment. Its market presence spans the People's Republic of China, Hong Kong, the United States, the United Kingdom, Germany, Italy, Spain, Mexico, and other international regions. The company, founded in 1996, is headquartered in Shenzhen, PRC.
IPO date
Nov 25, 2010
Employees
1,019
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT